HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

Top Medical News

CDC Finds Recovery Common From Rare Vaccine-Related Myocarditis

October 2nd 2022

Largest extended study of outcomes after rare myocarditis from mRNA COVID-19 vaccines finds most recover and regain quality of life.

September's Top 5 Infectious Disease Stories

September 30th 2022

Catch up on Contagion's top stories from the month of September.

COVID-19 Vaccine Boosters: Roadblocks, the Future, and Communicating the Benefits to Patients

September 30th 2022

“In the long run, what we will have is a virus that will become endemic in our population," said Donald J. Alcendor, MD. "The idea of thinking we can chase variants with boosters is a failed effort. We must realize that.”

CDC Updates Pneumococcal Conjugate Vaccine Recommendations

September 30th 2022

The federal agency recommends using either PCV13 or PCV15 as part of a 4-dose series for pediatric patients between the ages of 2-59 months.

Shionogi Reaches Endpoint for Phase 3 COVID-19 Pill

September 29th 2022

The investigational therapy demonstrated time to first resolution of the five COVID-19 symptoms was significantly reduced in those treated with low dose of medication.

Conference Coverage
View All >>

10 Years After HIV PrEP Approval, Uptake Lowest Among Highest Risk Groups

August 9th 2022

Expanding Medicaid and reducing stigma can bolster equitable HIV PrEP access, Dr. Patrick Sullivan says.

Biktarvy Effective for HIV Patients Coinfected With Hepatitis B

August 1st 2022

At AIDS 2022, Gilead presented data suggesting Biktarvy was a safe and effective complete HIV treatment regimen, including for those coinfected with hepatitis B.

Fostemsavir Improves Outcomes for Treatment-Resistant HIV Patients

July 30th 2022

After 5 years of treatment, fostemsavir improved immunologic response and virologic outcome in patients with highly resistant HIV infection.

The Patient Impact of CDI, Preventing Reoccurrence

June 1st 2022

A clinician discusses the disease burden of reoccurring CDI, but sees a silver lining in the new investigational therapies potentially changing the treatment paradigm for the better.

Video Interviews
View All >>
RBX2660 Could Heal Recurrent C Diff Patients, Physically and Psychologically
Can Zoonotic Exposure Predict COVID-19 Prevalence?
Can We Eliminate Hepatitis C?
Finding the Path Forward: HCV Co-Discoverer Has Developed Investigational Vaccine
PrEP at 10: Prescriptions Have Increased but Underutilization Remains a Challenge
Applying a Novel Gene Editing Therapy for Chronic Hepatitis B Treatment
10 Years After HIV PrEP Approval, Uptake Lowest Among Highest Risk Groups
In Low-Income Communities, Pharmacists Can Play a Critical Role in Vaccine Access
Infectious Disease Virologist: “Nobody Should be Scared of Paxlovid Rebound”
Trying to Reduce AMR Through Legislative Means
Utilizing Global Surveillance to Develop a Syphilis Vaccine
A Novel Device With COVID-19 Treatment Potential
Getting Men Screened and Being Proactive About Their Health
A Potential Monkeypox Therapy?
HPV Vaccination: A Prevention Measure Against Numerous Cancers
Podcasts
View All >>
Episode 6: World Hepatitis Day: Where Do We Go From Here?
ACIP Preferentially Recommends Fluzone High-Dose Influenza Vaccine for Seniors
Episode 5: “A Social and Political Pandemic”: HIV Disparities in LGBTQ+ People
Episode 4: Forging an Evolutionary Regulatory Path for Antibiotic Development
Episode 3: “We Treat People With Dignity”: An Alternative Healthcare Clinic for People Who Use Drugs
Episode 2: Vaccine Equality vs Equity with Dr. Jacinda Abdul-Mutakabbir
Episode 1: Vaccine Inequity With Dr. Leonard Friedland
Vaccine Race: The Pfizer Vaccine with William Schaffner, MD
COVID-19 Vaccine Race: FDA Advisory Committee Meeting with Donald Alcendor, PhD
Vaccine Race: Mei Mei Hu on Developing, Researching a COVID-19 Vaccine